Riskpilot← Back to searchSign inGet full accessCAW Medica AB
ABDissolvedOrg 5569196545Other education n.e.c. · NACE 8559Est. 20130 employees
Revenue 2021
SEK 0
EBITDA margin
—
-200% vs 2020
Equity ratio
85.5%
Financial strength
Net profit 2021
SEK 266K
+186% vs 2020
| Revenue | SEK 0 | — |
| EBITDA | SEK -33K | -200% |
| Net profit | SEK 266K | +186% |
| Total assets | SEK 628K | +20% |
| Equity | SEK 537K | +97% |
| Employees | 0 | — |
Legal name
CAW Medica AB
Org number
5569196545
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
18 januari 2013
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-02-28
Financial year
January – December
Company purpose
Bolaget skall bedriva sjukvårds- och hälsoarbete, vidare skall bolaget bedriva utbildning och rådgivning inom motsvarande områden samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 52 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 20 | −34 | −22 | −11 | −33 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 20 | −34 | −22 | −11 | −33 |
| Net financials | 4 | 24 | — | — | 117 |
| Profit before tax | 18 | −1 | −1 | 120 | 308 |
| Tax | −5 | −0 | −0 | −27 | −42 |
| Net profit | 13 | −1 | −1 | 93 | 266 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 1 077 | 560 | 534 | 522 | 628 |
| Equity | 682 | 181 | 179 | 272 | 537 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 11 | 4 | 0 | 27 | 91 |
| Total debt | 11 | 4 | — | 27 | 91 |
EBITDA margin
-3300000.0%
This company
15.8%
Market median
-20886176% vs market
20172021
Equity ratio
85.5%
This company
38.2%
Market median
+124% vs market
20172021
Return on equity
49.5%
This company
18.4%
Market median
+169% vs market
20172021
Net profit margin
26600000.0%
This company
8.1%
Market median
+328394962% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-02-28
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-03-01 – 2020-02-29
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-03-01 – 2019-02-28
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-03-01 – 2018-02-28
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-03-01 – 2017-02-28
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
EA Chief Executive Officer | Chief Executive Officer | 2021 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CAW Medica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Anders Westman | Chief Executive Officer | 0 companies |
| Leif Gustav Andersson | Deputy Board Member | 0 companies |
| Inger Margareta Dahle | Deputy Board Member | 0 companies |
| Bengt Junior Niklas Nygårds | Board of Directors | 0 companies |
| Ulrika Margareta Ahlholm | Deputy Board Member | 0 companies |
| Christina Westman | Deputy Board Member | 0 companies |